science communication
D partners
industrial partners
Innovative peptides
unique technologies
leading academic partners
Spain
INPACT consortium
new resistant peptides
new drugs
unique knowledge
proprietary technologies
biopharmaceutical drug development
peptide drugsâ€™ technologies
ultra-resistant cyclic peptides
drug formulations
societal development
pre-clinical development of innovative drugs
cyclic peptide-drug chimeras
Brazil
international science funding
pathogenic bacteria
Portugal
industrial R
judicious exchange of knowledge
trans-barrier delivery of drugs
business school
prostate cancer
advancement of Europe
D project
supercharged viral proteins-derived cell-penetrating peptides
consolidated media partner
highest possible level
consolidated biotech SMEs
product market targeting
advances
selected cancers
Dengue virus
education
skills
Ciencia Hoje
Rio
bacterial killing
Janeiro
young researchers
use of research
experts
training
IESE
Barcelona
entrepreneurship
technology
turn
expertise
career path
perfect environment
life-long learning perspective
economic growth
US universities
University of Stanford
biofilms
addition
Australia
integrative effort
contribution
aureus